Neurodyn Life Sciences competitive analysis

Latest publications and patents of Neurodyn Life Sciences New

Explore the latest publications and patents granted to Neurodyn Life Sciences, showcasing their recent innovations and technological advancements.

Last updated on: Sep 30, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Neurodyn Life Sciences

Oct 3, 2018Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S DiseaseRevoked

Explore Neurodyn Life Sciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 3, 2018Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S Disease2

Latest PTAB cases involving Neurodyn Life Sciences

Discover the latest PTAB cases involving Neurodyn Life Sciences, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Neurodyn Life Sciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
NEURODYN LIFE SCIENCES - 2 - - Non-Active
CMS CAMERON MCKENNA NABARRO OLSWANG11 - - - Highly Aggressive
MATHYS & SQUIRE49 - - - Highly Aggressive